These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
665 related articles for article (PubMed ID: 22068627)
1. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder. Calahorro F; Ruiz-Rubio M Invert Neurosci; 2011 Dec; 11(2):73-83. PubMed ID: 22068627 [TBL] [Abstract][Full Text] [Related]
2. The Functional Assessment of LRRK2 in Caenorhabditis elegans Mechanosensory Neurons. Kuwahara T Methods Mol Biol; 2021; 2322():175-184. PubMed ID: 34043203 [TBL] [Abstract][Full Text] [Related]
3. Modelling the functional genomics of Parkinson's disease in Caenorhabditis elegans: LRRK2 and beyond. Chandler RJ; Cogo S; Lewis PA; Kevei E Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34397087 [TBL] [Abstract][Full Text] [Related]
4. Copper-mediated neurotoxicity and genetic vulnerability in the background of neurodegenerative diseases in C. elegans. Weishaupt AK; Ruecker L; Meiners T; Schwerdtle T; Silva Avila D; Aschner M; Bornhorst J Toxicol Sci; 2024 Oct; 201(2):254-262. PubMed ID: 39067045 [TBL] [Abstract][Full Text] [Related]
5. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans. Bornhorst J; Chakraborty S; Meyer S; Lohren H; Brinkhaus SG; Knight AL; Caldwell KA; Caldwell GA; Karst U; Schwerdtle T; Bowman A; Aschner M Metallomics; 2014 Mar; 6(3):476-90. PubMed ID: 24452053 [TBL] [Abstract][Full Text] [Related]
6. Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration. Griffin EF; Yan X; Caldwell KA; Caldwell GA Hum Mol Genet; 2018 Dec; 27(24):4176-4193. PubMed ID: 30508205 [TBL] [Abstract][Full Text] [Related]
7. LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease. Yao C; El Khoury R; Wang W; Byrd TA; Pehek EA; Thacker C; Zhu X; Smith MA; Wilson-Delfosse AL; Chen SG Neurobiol Dis; 2010 Oct; 40(1):73-81. PubMed ID: 20382224 [TBL] [Abstract][Full Text] [Related]
8. Regulation of TIR-1/SARM-1 by miR-71 Protects Dopaminergic Neurons in a Naidoo D; de Lencastre A Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201481 [TBL] [Abstract][Full Text] [Related]
9. Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans. Yuan Y; Cao P; Smith MA; Kramp K; Huang Y; Hisamoto N; Matsumoto K; Hatzoglou M; Jin H; Feng Z PLoS One; 2011; 6(8):e22354. PubMed ID: 21857923 [TBL] [Abstract][Full Text] [Related]
10. Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease. Johnson WM; Yao C; Siedlak SL; Wang W; Zhu X; Caldwell GA; Wilson-Delfosse AL; Mieyal JJ; Chen SG Hum Mol Genet; 2015 Mar; 24(5):1322-35. PubMed ID: 25355420 [TBL] [Abstract][Full Text] [Related]
11. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433 [TBL] [Abstract][Full Text] [Related]
12. Caenorhabditis elegans hub genes that respond to amyloid beta are homologs of genes involved in human Alzheimer's disease. Godini R; Pocock R; Fallahi H PLoS One; 2019; 14(7):e0219486. PubMed ID: 31291334 [TBL] [Abstract][Full Text] [Related]
13. Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans. Huang X; Wang C; Chen L; Zhang T; Leung KL; Wong G Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166203. PubMed ID: 34146705 [TBL] [Abstract][Full Text] [Related]
14. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans. Wang C; Saar V; Leung KL; Chen L; Wong G Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592 [TBL] [Abstract][Full Text] [Related]
15. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease. Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384 [TBL] [Abstract][Full Text] [Related]
16. Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system. Ewald CY; Li C Brain Struct Funct; 2010 Mar; 214(2-3):263-83. PubMed ID: 20012092 [TBL] [Abstract][Full Text] [Related]
17. Novel C. elegans models of Lewy body disease reveal pathological protein interactions and widespread miRNA dysregulation. Li R; Huang X; Shen L; Zhang T; Liu N; Hou X; Wong G Cell Mol Life Sci; 2024 Aug; 81(1):377. PubMed ID: 39212733 [TBL] [Abstract][Full Text] [Related]
18. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro. Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579 [TBL] [Abstract][Full Text] [Related]
19. Synaptic dysfunction in Parkinson's disease. Picconi B; Piccoli G; Calabresi P Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072 [TBL] [Abstract][Full Text] [Related]